Citadel Advisors
WGRX

Citadel Advisors’s Wellgistics Health WGRX Stock Holding History

Citadel Advisors’s Portfolio WGRX Stock Details WGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-596
Closed -$129K – 15708
2025
Q1 		$129K Buy
+596
New +$101K ﹤0.01% 11105

Other funds holding WGRX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFIC
Valley Forge Investment Consultants Audubon, Pennsylvania $334M AUM 17.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

Citadel Advisors's WGRX Position: Q2 2025 in Review

Citadel Advisors sold out of Wellgistics Health (WGRX) in Q2 2025, closing a stake of 596 shares — an estimated $129K sold.

Citadel Advisors first reported a position in WGRX in Q1 2025 and held it in 1 quarter. The position peaked at $129K in Q1 2025. 6 funds tracked by Wall St. Rank hold WGRX as of Q2 2025.

  • Citadel Advisors reported no remaining Wellgistics Health position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 596 Wellgistics Health shares in Q2 2025, an estimated $129K.
  • Citadel Advisors first reported a position in Wellgistics Health in Q1 2025 and held it in 1 quarter.
  • Citadel Advisors's Wellgistics Health position peaked at $129K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Wellgistics Health as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.